Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer J Jordan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Genes & Development|May 14, 2013
Human ALKBH7 is required for alkylation and oxidation-induced programmed necrosisDragony Fu, Jennifer J Jordan, Leona D Samson
Plos One|July 7, 2015
Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional AssayVasundhara Sharma, Jennifer J Jordan, Yari Ciribilli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2017
In vivo measurements of interindividual differences in DNA glycosylases and APE1 activitiesIsaac A Chaim, Zachary D Nagel, Jennifer J Jordan, et al.
Molecular Cancer Research : MCR|April 22, 2010
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivationJennifer J Jordan, Alberto Inga, Kathleen Conway, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Low-level p53 expression changes transactivation rules and reveals superactivating sequencesJennifer J Jordan, Daniel Menendez, Jenia Sharav, et al.
Plos Genetics|August 21, 2008
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53Jennifer J Jordan, Daniel Menendez, Alberto Inga, et al.
Gene|November 18, 2005
Use of a restriction endonuclease cytotoxicity assay to identify inducible GAL1 promoter variants with reduced basal activityL Kevin Lewis, Kirill Lobachev, James W Westmoreland, et al.
Cell Death & Disease|July 21, 2017
ALKBH7 drives a tissue and sex-specific necrotic cell death response following alkylation-induced damageJennifer J Jordan, Sophea Chhim, Carrie M Margulies, et al.
BJU International|December 13, 2006
Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?Philippe E Spiess, Andrew K Lee, Joseph E Busby, et al.
Human Molecular Genetics|January 23, 2010
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanomaAlessandra Bisio, Sabina Nasti, Jennifer J Jordan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Genes & Development|May 14, 2013
Human ALKBH7 is required for alkylation and oxidation-induced programmed necrosisDragony Fu, Jennifer J Jordan, Leona D Samson
Plos One|July 7, 2015
Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional AssayVasundhara Sharma, Jennifer J Jordan, Yari Ciribilli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2017
In vivo measurements of interindividual differences in DNA glycosylases and APE1 activitiesIsaac A Chaim, Zachary D Nagel, Jennifer J Jordan, et al.
Molecular Cancer Research : MCR|April 22, 2010
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivationJennifer J Jordan, Alberto Inga, Kathleen Conway, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Low-level p53 expression changes transactivation rules and reveals superactivating sequencesJennifer J Jordan, Daniel Menendez, Jenia Sharav, et al.
Plos Genetics|August 21, 2008
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53Jennifer J Jordan, Daniel Menendez, Alberto Inga, et al.
Gene|November 18, 2005
Use of a restriction endonuclease cytotoxicity assay to identify inducible GAL1 promoter variants with reduced basal activityL Kevin Lewis, Kirill Lobachev, James W Westmoreland, et al.
Cell Death & Disease|July 21, 2017
ALKBH7 drives a tissue and sex-specific necrotic cell death response following alkylation-induced damageJennifer J Jordan, Sophea Chhim, Carrie M Margulies, et al.
BJU International|December 13, 2006
Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?Philippe E Spiess, Andrew K Lee, Joseph E Busby, et al.
Human Molecular Genetics|January 23, 2010
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanomaAlessandra Bisio, Sabina Nasti, Jennifer J Jordan, et al.
Pageof 2